Bassem Chehab, MD
Enriched profileMedical director, Heart Valve Clinic and Structural Heart program, Ascension Via Christi St. Francis · Ascension Via Christi Cardiology
Bassem Chehab is Medical director, Heart Valve Clinic and Structural Heart program, Ascension Via Christi St. Francis at Ascension Via Christi Cardiology. OpenAlex indexes 90 publications with 1,381 citations (h-index 20); ClinicalTrials.gov lists 9 registered studies with this person as an investigator.
Data verified 28 Oct 2026
Overview
Updated 28 Oct 2026
Bassem Chehab, M.D., is Medical director, Heart Valve Clinic and Structural Heart program, Ascension Via Christi St. Francis at Ascension Via Christi Cardiology. The public record shows 90 publications with 1,381 citations (h-index 20), centered on Coronary Interventions and Diagnostics, Cardiac Valve Diseases and Treatments, Antiplatelet Therapy and Cardiovascular Diseases. It also documents an investigator role on 9 registered clinical trials, industry payments reported by 32 companies.
- Top research focus: Coronary Interventions and Diagnostics
- 9 registered trials on ClinicalTrials.gov
- Open Payments reporting from 32 companies
Generated from the cited public record · current as of 28 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 5 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 25.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 28 Oct 2026
Listed as an investigator on 9 registered studies on ClinicalTrials.gov. The most recent:
- Abbott Cephea Mitral Valve Disease Registry
Sponsor: Abbott Medical Devices
- REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE
Sponsor: Medtronic Cardiovascular
Industry payments
Updated 28 Oct 2026
32 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year202555 payments$45,989openpaymentsdata.cms.gov ↗
- Edwards Lifesciences CorporationProgram year202528 payments$18,251openpaymentsdata.cms.gov ↗
- ABIOMEDProgram year202513 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
78.1%Beta blocker18.2%Metoprolol Tartrate54%Carvedilol24%Metoprolol Succinate20%Sotalol2%Atenolol1%Part D<11 patientsLoop diuretic13.3%Furosemide78%Bumetanide20%Torsemide1%Part D<11 patients+ 17 more classes in this area
Blood & clotting
15.9%Factor Xa inhibitor8.5%Eliquis80%Xarelto20%Part D≥127 patientsP2Y12 inhibitor5.5%Clopidogrel91%Brilinta6%Prasugrel Hcl2%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
5.8%Potassium supplement3.1%Potassium Chloride90%Klor-Con M2010%Part D≥84 patientsProton pump inhibitor2.5%Pantoprazole Sodium100%Part D≥77 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Abbreviated DAPT Regimens Across the Entire Spectrum of Bleeding Risk According to the PRECISE-HBR Score
JACC: Cardiovascular Interventions
2026 - Tricuspid valve replacement outcomes by baseline tricuspid regurgitation severity: the TRISCEND II trial
European Heart Journal
2025 - Transcatheter Mitral Valve Replacement for Severe Mitral Annular Calcification
Journal of the American College of Cardiology
2025 - 1-Month or 3-Month DAPT in Women and Men at High Bleeding Risk Undergoing PCI
JACC: Cardiovascular Interventions
2025
Most-cited works
by citation count (OpenAlex)- 01
- 02
- 03Contemporary Outcomes Following Transcatheter Edge-to-Edge RepairArticle108 citations2023
- 04
- 05Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCIArticle82 citations2021
Network
Updated 28 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 28 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healthcare.ascension.org ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healthcare.ascension.org ↗
- Board certification: American Board of Internal Medicine
Cardiovascular Disease
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healthcare.ascension.org ↗ - Board certification: American Board of Internal Medicine
Interventional Cardiology
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healthcare.ascension.org ↗
Editorial & leadership roles
journal and society appointments- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healthcare.ascension.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)